Tratamiento e historia natural de la Hepatitis crónica C en pacientes coinfectados por VIH-1
作者： Javier Murillas Angoiti
DOI:
关键词: Standardized mortality ratio 、 Medicine 、 Internal medicine 、 Improved survival 、 Virology 、 Alcohol abuse 、 Incidence (epidemiology) 、 Gastroenterology 、 Population 、 Virus 、 Cohort 、 Liver disease
摘要: Background: The likely increased incidence of hepatocarcinoma (HCC) in HIV-1 infected patients has not yet been demonstrated. Methods: We studied all cases HCC occurring our hospital during the past 15 years. Incidence and survival time were compared with those general population same area study. Results: found 6 a cohort 2383 between 1986 2001. This is higher than expected rate population, standardized ratio 13.95. Chronic hepatitis virus infection alcohol abuse present four two cases, respectively. In one patient, no liver disease was known before surrounding normal necropsy Conclusion: improved on highly active antiretroviral treatment (HAART) increasing end-stage these caused by chronic may be responsible for an increase patients. D 2005 Elsevier B.V. All rights reserved.
tesisenred.net 参考文章(303)
Annalisa Mainini, Monica Schiavini, Elena Angeli, Piergiorgio Duca, Riccardo Giorgi, Guido Gubertini, Antonietta Cargnel, Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART. Antiviral Therapy. ,vol. 10, pp. 309- 317 ,(2005)
Vincent Soriano, Celia Miralles, Miguel Angel Berdún, Elena Losada, Koldo Aguirrebengoa, Antonio Ocampo, Piedad Arazo, Manuel Cervantes, Ignacio De Los Santos, Isabel San Joaquín, Santiago Echeverria, María J Galindo, Victor Asensi, Pablo Barreiro, Julio Sola, Juan J Hernandez-Burruezo, Josep Guardiola, Francisco Blanco, Luz Martin-Carbonero, Javier García-Samaniego, Marina Nuñez, Premature treatment discontinuation in HIV/HCV- coinfected patients receiving pegylated interferon plus weight-based ribavirin Antiviral Therapy. ,vol. 12, pp. 469- 476 ,(2007)
M. Espinosa, M.D. Arenas, M.D. Aumente, G. Barril, J.M. Buades, B. Aviles, D. Carretero, M.A. Alvarez-Lara, F. Carnicer, A.M. Malo, P. Aljama, Anemia associated with pegylated interferon-alpha2a and alpha2b therapy in hemodialysis patients. Clinical Nephrology. ,vol. 67, pp. 366- 373 ,(2007) , 10.5414/CNP67366
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study JAMA Internal Medicine. ,vol. 166, pp. 1632- 1641 ,(2006) , 10.1001/ARCHINTE.166.15.1632
José A Mira, Luis F López-Cortés, Dolores Merino, Ana Arizcorreta-Yarza, Antonio Rivero, Antonio Collado, María J Ríos-Villegas, Mercedes González-Serrano, Manuel Torres-Tortosa, Juan Macías, Bárbara Valera-Bestard, Elisa Fernández-Fuertes, José A Girón-González, Fernando Lozano, Juan A Pineda, Grupo para el Estudio de las Hepatitis Víricas de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI), Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients. Antiviral Therapy. ,vol. 12, pp. 1225- 1235 ,(2007)
Sonia Rodríguez-Nóvoa, Luz Martín-Carbonero, Eugenia Vispo, Luis F López-Cortes, Ivana Maida, Ignacio Santos, Pablo Barreiro, Dolores Merino, Antonio Rivero, Vincent Soriano, José A Mira, Juan A Pineda, Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir. Antiviral Therapy. ,vol. 13, pp. 429- 437 ,(2008)
Chun-Jen Liu, Wen-Ling Huang, Pei-Jer Chen, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen, End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B World Journal of Gastroenterology. ,vol. 10, pp. 3574- 3578 ,(2004) , 10.3748/WJG.V10.I24.3574
Montserrat Laguno, Jordi Blanch, Javier Murillas, Jose Luis Blanco, Agathe Leon, Montserrat Lonca, Maria Larrousse, Alejandra Biglia, Esteban Martinez, Felipe Garcia, Jose M Miró, Joan de Pablo, Josep M Gatell, Josep Mallolas, None, Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C. Antiviral Therapy. ,vol. 9, pp. 905- 909 ,(2004)
María J Perez-Elías, Fernando Dronda, Rafael Bárcena, Enrique Navas, Jose L Casado, Carmen Quereda, Santiago Moreno, Alfonso Muriel, Antonio Antela, Leonor Moreno, Ana Moreno, High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin. Antiviral Therapy. ,vol. 9, pp. 133- 138 ,(2004)
Nicolas A Margot, Michael D Miller, None, In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1. Antiviral Therapy. ,vol. 10, pp. 343- 348 ,(2005)